December 7, 2018
MARKET OUTLOOKThe accelerated approvals of Kymriah (Novartis) for the treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) and Yescarta (Kite…
December 6, 2018
December 5, 2018
December 4, 2018
November 30, 2018
November 30, 2018
November 29, 2018
November 29, 2018
November 29, 2018
November 28, 2018
November 28, 2018
Market OutlookThis report examines the market access factors that influence the success of therapies for chronic heart failure (CHF), with a special focus on payers’ and cardiologists’…
November 23, 2018
November 22, 2018
November 21, 2018
November 19, 2018